Todd Hagopian has been watching President Trump's first weeks in office to determine how Trump will affect Biotech stocks. I've asked Todd to tell us which areas of Biotech look the most attractive to him under Trump's Administration.
Todd Hagopian has been watching President Trump's first weeks in office to determine how Trump will affect Biotech stocks. I've asked Todd to tell us which areas of Biotech look the most attractive to him under Trump's Administration.
Share this Article
Recommended